<SEC-DOCUMENT>0001567619-20-010136.txt : 20200514
<SEC-HEADER>0001567619-20-010136.hdr.sgml : 20200514
<ACCEPTANCE-DATETIME>20200514164024
ACCESSION NUMBER:		0001567619-20-010136
CONFORMED SUBMISSION TYPE:	13F-HR
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200331
FILED AS OF DATE:		20200514
DATE AS OF CHANGE:		20200514
EFFECTIVENESS DATE:		20200514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Stonepine Capital Management, LLC
		CENTRAL INDEX KEY:			0001440771
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		13F-HR
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	028-17175
		FILM NUMBER:		20878442

	BUSINESS ADDRESS:	
		STREET 1:		919 NW BOND STREET
		STREET 2:		SUITE 204
		CITY:			BEND
		STATE:			OR
		ZIP:			97703
		BUSINESS PHONE:		541.647.5664

	MAIL ADDRESS:	
		STREET 1:		919 NW BOND STREET
		STREET 2:		SUITE 204
		CITY:			BEND
		STATE:			OR
		ZIP:			97703
</SEC-HEADER>
<DOCUMENT>
<TYPE>13F-HR
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xmlns="http://www.sec.gov/edgar/thirteenffiler" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>13F-HR</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <flags>
        <confirmingCopyFlag>false</confirmingCopyFlag>
        <returnCopyFlag>true</returnCopyFlag>
        <overrideInternetFlag>false</overrideInternetFlag>
      </flags>
      <filer>
        <credentials>
          <cik>0001440771</cik>
          <ccc>XXXXXXXX</ccc>
        </credentials>
      </filer>
      <periodOfReport>03-31-2020</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <reportCalendarOrQuarter>03-31-2020</reportCalendarOrQuarter>
      <filingManager>
        <name>Stonepine Capital Management, LLC</name>
        <address>
          <com:street1>919 NW BOND STREET</com:street1>
          <com:street2>SUITE 204</com:street2>
          <com:city>BEND</com:city>
          <com:stateOrCountry>OR</com:stateOrCountry>
          <com:zipCode>97703</com:zipCode>
        </address>
      </filingManager>
      <reportType>13F HOLDINGS REPORT</reportType>
      <form13FFileNumber>028-17175</form13FFileNumber>
      <provideInfoForInstruction5>N</provideInfoForInstruction5>
    </coverPage>
    <signatureBlock>
      <name>Timothy P. Lynch</name>
      <title>Managing Member</title>
      <phone>541-647-5673</phone>
      <signature>/s/ Timothy P. Lynch</signature>
      <city>Bend</city>
      <stateOrCountry>OR</stateOrCountry>
      <signatureDate>05-14-2020</signatureDate>
    </signatureBlock>
    <summaryPage>
      <otherIncludedManagersCount>0</otherIncludedManagersCount>
      <tableEntryTotal>27</tableEntryTotal>
      <tableValueTotal>94557</tableValueTotal>
      <isConfidentialOmitted>false</isConfidentialOmitted>
    </summaryPage>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>INFORMATION TABLE
<SEQUENCE>2
<FILENAME>form13fInfoTable.xml
<TEXT>
<XML>
<informationTable xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable">		<infoTable>
			<nameOfIssuer>AEGERION PHARMACEUTICALSAEGR 5 04/01/25</nameOfIssuer>
			<titleOfClass>NOTE 5.000% 4/0</titleOfClass>
			<cusip>00767EAC6</cusip>
			<value>2886</value>
			<shrsOrPrnAmt>
				<sshPrnamt>3037627</sshPrnamt>
				<sshPrnamtType>PRN</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>3037627</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>ADAMAS PHARMACEUTICALS INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>00548A106</cusip>
			<value>3361</value>
			<shrsOrPrnAmt>
				<sshPrnamt>1162876</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>1162876</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>AFFIMED NV</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>N01045108</cusip>
			<value>4740</value>
			<shrsOrPrnAmt>
				<sshPrnamt>3000000</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>3000000</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>APPLIED GENETIC TECHNOLOGIES</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>03820J100</cusip>
			<value>1925</value>
			<shrsOrPrnAmt>
				<sshPrnamt>586969</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>586969</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>AMARIN CORP PLC -ADR</nameOfIssuer>
			<titleOfClass>SPONS ADR NEW</titleOfClass>
			<cusip>023111206</cusip>
			<value>5252</value>
			<shrsOrPrnAmt>
				<sshPrnamt>1313100</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>1313100</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>APOLLO ENDOSURGERY INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>03767D108</cusip>
			<value>3233</value>
			<shrsOrPrnAmt>
				<sshPrnamt>1683861</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>1683861</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>ANTARES PHARMA INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>036642106</cusip>
			<value>357</value>
			<shrsOrPrnAmt>
				<sshPrnamt>151189</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>151189</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>BIODELIVERY SCIENCES INTL</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>09060J106</cusip>
			<value>2861</value>
			<shrsOrPrnAmt>
				<sshPrnamt>755000</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>755000</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>BAUDAX BIO INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>07160F107</cusip>
			<value>1513</value>
			<shrsOrPrnAmt>
				<sshPrnamt>610200</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>610200</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>CATALYST BIOSCIENCES INC</nameOfIssuer>
			<titleOfClass>COM NEW</titleOfClass>
			<cusip>14888D208</cusip>
			<value>4454</value>
			<shrsOrPrnAmt>
				<sshPrnamt>1019196</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>1019196</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>CIDARA THERAPEUTICS INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>171757107</cusip>
			<value>3231</value>
			<shrsOrPrnAmt>
				<sshPrnamt>1302981</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>1302981</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>CHIASMA INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>16706W102</cusip>
			<value>2716</value>
			<shrsOrPrnAmt>
				<sshPrnamt>744134</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>744134</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>CUMBERLAND PHARMACEUTICALS</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>230770109</cusip>
			<value>3295</value>
			<shrsOrPrnAmt>
				<sshPrnamt>907735</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>907735</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>CTI BIOPHARMA CORP</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>12648L601</cusip>
			<value>5916</value>
			<shrsOrPrnAmt>
				<sshPrnamt>6430637</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>6430637</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>DIAMEDICA THERAPEUTICS INC</nameOfIssuer>
			<titleOfClass>COM NEW</titleOfClass>
			<cusip>25253X207</cusip>
			<value>2311</value>
			<shrsOrPrnAmt>
				<sshPrnamt>825297</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>825297</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>EVOLUS INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>30052C107</cusip>
			<value>3415</value>
			<shrsOrPrnAmt>
				<sshPrnamt>822960</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>822960</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>HTG MOLECULAR DIAGNOSTICS</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>40434H104</cusip>
			<value>323</value>
			<shrsOrPrnAmt>
				<sshPrnamt>992641</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>992641</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>INTERPACE BIOSCIENCES INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>46062X303</cusip>
			<value>924</value>
			<shrsOrPrnAmt>
				<sshPrnamt>178295</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>178295</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>IVERIC BIO INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>46583P102</cusip>
			<value>8888</value>
			<shrsOrPrnAmt>
				<sshPrnamt>2583786</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>2583786</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>LIGAND PHARMACEUTICALS</nameOfIssuer>
			<titleOfClass>COM NEW</titleOfClass>
			<cusip>53220K504</cusip>
			<value>11702</value>
			<shrsOrPrnAmt>
				<sshPrnamt>160919</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>160919</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>NEOS THERAPEUTICS INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>64052L106</cusip>
			<value>3518</value>
			<shrsOrPrnAmt>
				<sshPrnamt>4690146</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>4690146</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>OPIANT PHARMACEUTICALS INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>683750103</cusip>
			<value>3649</value>
			<shrsOrPrnAmt>
				<sshPrnamt>380948</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>380948</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>OXFORD IMMUNOTEC GLOBAL PLC</nameOfIssuer>
			<titleOfClass>ORD SHS</titleOfClass>
			<cusip>G6855A103</cusip>
			<value>3467</value>
			<shrsOrPrnAmt>
				<sshPrnamt>374431</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>374431</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>RIGEL PHARMACEUTICALS INC</nameOfIssuer>
			<titleOfClass>COM NEW</titleOfClass>
			<cusip>766559603</cusip>
			<value>16</value>
			<shrsOrPrnAmt>
				<sshPrnamt>10000</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>10000</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>SEASPINE HOLDINGS CORP</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>81255T108</cusip>
			<value>2068</value>
			<shrsOrPrnAmt>
				<sshPrnamt>253131</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>253131</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>STEMLINE THERAPEUTICS INC</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>85858C107</cusip>
			<value>4291</value>
			<shrsOrPrnAmt>
				<sshPrnamt>886632</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>886632</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
		<infoTable>
			<nameOfIssuer>XOMA CORP</nameOfIssuer>
			<titleOfClass>COM</titleOfClass>
			<cusip>98419J206</cusip>
			<value>4245</value>
			<shrsOrPrnAmt>
				<sshPrnamt>208600</sshPrnamt>
				<sshPrnamtType>SH</sshPrnamtType>
			</shrsOrPrnAmt>
			<investmentDiscretion>SOLE</investmentDiscretion>
			<votingAuthority>
				<Sole>208600</Sole>
				<Shared>0</Shared>
				<None>0</None>
			</votingAuthority>
		</infoTable>
</informationTable>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
